211
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

NIPAAm-containing amphiphilic block copolymers with tailored LCST: Aggregation behavior, cytotoxicity and evaluation as carriers of indomethacin, tetracycline and doxorubicin

, , , &
Pages 759-772 | Received 19 Dec 2017, Accepted 08 Feb 2019, Published online: 14 May 2019
 

Abstract

Nanocarriers based on amphiphilic block copolymers, with tailored temperature and pH responsiveness, were prepared. The hydrophilic blocks consist of temperature-sensitive [N-isopropylacrylamide (NIPAAm)] or NIPAAm plus pH-sensitive units [5-methacryloyloxy pentatonic acid (5MPA) or 4-methacryloyloxy benzoic acid (4MBA)], while the hydrophobic block is composed of n-hexyl acrylate (HA) or styrene (ST). Particle sizes were within the suitable range for the desired application (30–182 nm). Drug loading was achieved via an organic solvent-free method and a THF-buffer method leading to drug loadings of indomethacin, tetracycline and doxorubicin of up to 11, 11 and 60 wt%, respectively. In vitro release kinetics were performed under simulated physiological conditions (pH 7.4 and 37 °C; pH 6.0 and 40 °C) and show differences depending on the copolymer composition. The average kinetic data were well fitted to the mathematical model of Peppas. NIPAAm-containing copolymers were slight or non-cytotoxic for rat primary hepatocytes at concentrations less than 200 µg mL−1. Some of the polymeric aggregates prepared may find application as pharmaceutical carriers.

Acknowledgements

This investigation was supported by the Consejo Nacional de Ciencia y Tecnología (CONACYT) of Mexico under grants CB-2012/178709 and INFR-2016/26955; furthermore by the Universidad Autónoma de Sinaloa under grant PROFAPI2014/156. Technical support by Y. Cristerna-Madrigal (UAS), M. Díaz-Duarte and I.A. Rivero (IT-Tijuana) is gratefully acknowledged.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.